Literature DB >> 20501641

Disruption of AMPKalpha1 signaling prevents AICAR-induced inhibition of AS160/TBC1D4 phosphorylation and glucose uptake in primary rat adipocytes.

Mandeep P Gaidhu1, Robert L S Perry, Fawad Noor, Rolando B Ceddia.   

Abstract

The aim of this study was to investigate the molecular mechanisms by which AMP-kinase (AMPK) activation inhibits basal and insulin-stimulated glucose uptake in primary adipocytes. Rat epididymal adipocytes were exposed to 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside (AICAR) for 1 h. Subsequently, basal and insulin-stimulated glucose uptake and the phosphorylation of AMPK, acetyl-CoA carboxylase, Akt, and the Akt substrate of 160 kDa (AS160/TBC1D4) were determined. In order to investigate whether these effects of AICAR were mediated by AMPK activation, these parameters were also assessed in adipocytes either expressing LacZ (control) or a kinase-dead AMPKalpha1 mutant. AICAR increased AMPK activation without affecting basal and insulin-stimulated Akt1/2 phosphorylation on Thr(308) and Ser(473) residues. However, AMPK activation suppressed the phosphorylation of AS160/TBC1D4 and its interaction with the 14-3-3 signal transduction-regulatory protein, which was accompanied by significant reductions in plasma membrane glucose transporter 4 content and glucose uptake under basal and insulin-stimulated conditions. Phosphorylation of Akt substrates glycogen synthase kinase 3alpha and -beta were unaltered by AICAR, indicating that the AMPK-regulatory effects were specific to the AS160/TBC1D4 signaling pathway. Expression of the kinase-dead AMPKalpha1 mutant fully prevented the suppression of AS160/TBC1D4 phosphorylation, plasma membrane glucose transporter 4 content, and the inhibitory effect of AICAR-induced AMPK activation on basal and insulin-stimulated glucose uptake. This study is the first to provide evidence that disruption of AMPKalpha1 signaling prevents the suppressive effects of AMPK activation on AS160/TBC1D4 phosphorylation and glucose uptake, indicating that insulin-signaling steps that are common to white adipose tissue and skeletal muscle regulation of glucose uptake are distinctly affected by AMPK activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501641      PMCID: PMC5417465          DOI: 10.1210/me.2009-0502

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  15 in total

Review 1.  Subcellular fractionation of adipocytes and 3T3-L1 cells.

Authors:  H G Joost; A Schürmann
Journal:  Methods Mol Biol       Date:  2001

Review 2.  The GLUT4 code.

Authors:  Mark Larance; Georg Ramm; David E James
Journal:  Mol Endocrinol       Date:  2007-08-23

3.  Inhibition of insulin-stimulated glycogen synthesis by 5-aminoimidasole-4-carboxamide-1-beta-d-ribofuranoside-induced adenosine 5'-monophosphate-activated protein kinase activation: interactions with Akt, glycogen synthase kinase 3-3alpha/beta, and glycogen synthase in isolated rat soleus muscle.

Authors:  S Fediuc; M P Gaidhu; R B Ceddia
Journal:  Endocrinology       Date:  2006-07-27       Impact factor: 4.736

4.  5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes.

Authors:  Mandeep Pinky Gaidhu; Sergiu Fediuc; Rolando Bacis Ceddia
Journal:  J Biol Chem       Date:  2006-07-01       Impact factor: 5.157

5.  The regulation of AMP-activated protein kinase by phosphorylation.

Authors:  S C Stein; A Woods; N A Jones; M D Davison; D Carling
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

Review 6.  AMP-activated protein kinase signaling in metabolic regulation.

Authors:  Yun Chau Long; Juleen R Zierath
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 7.  AMP-activated protein kinase: balancing the scales.

Authors:  David Carling
Journal:  Biochimie       Date:  2005-01       Impact factor: 4.079

8.  5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes.

Authors:  I P Salt; J M Connell; G W Gould
Journal:  Diabetes       Date:  2000-10       Impact factor: 9.461

9.  Prolonged AICAR-induced AMP-kinase activation promotes energy dissipation in white adipocytes: novel mechanisms integrating HSL and ATGL.

Authors:  Mandeep P Gaidhu; Sergiu Fediuc; Nicole M Anthony; Mandy So; Mani Mirpourian; Robert L S Perry; Rolando B Ceddia
Journal:  J Lipid Res       Date:  2008-12-02       Impact factor: 5.922

10.  Inhibition of GLUT4 translocation by Tbc1d1, a Rab GTPase-activating protein abundant in skeletal muscle, is partially relieved by AMP-activated protein kinase activation.

Authors:  Jose A Chavez; William G Roach; Susanna R Keller; William S Lane; Gustav E Lienhard
Journal:  J Biol Chem       Date:  2008-02-07       Impact factor: 5.157

View more
  7 in total

Review 1.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

2.  Chronic AMP-kinase activation with AICAR reduces adiposity by remodeling adipocyte metabolism and increasing leptin sensitivity.

Authors:  Mandeep P Gaidhu; Andrea Frontini; Steven Hung; Kathryn Pistor; Saverio Cinti; Rolando B Ceddia
Journal:  J Lipid Res       Date:  2011-07-07       Impact factor: 5.922

3.  AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study.

Authors:  J G Boyle; P J Logan; G C Jones; M Small; N Sattar; J M C Connell; S J Cleland; I P Salt
Journal:  Diabetologia       Date:  2011-04-01       Impact factor: 10.122

4.  Leptin reduces the expression and increases the phosphorylation of the negative regulators of GLUT4 traffic TBC1D1 and TBC1D4 in muscle of ob/ob mice.

Authors:  Neira Sáinz; Amaia Rodríguez; Victoria Catalán; Sara Becerril; Beatriz Ramírez; Andoni Lancha; Emma Burgos-Ramos; Javier Gómez-Ambrosi; Gema Frühbeck
Journal:  PLoS One       Date:  2012-01-09       Impact factor: 3.240

Review 5.  Perivascular fat, AMP-activated protein kinase and vascular diseases.

Authors:  T A M Almabrouk; M A Ewart; I P Salt; S Kennedy
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

6.  Acute regulation of 5'-AMP-activated protein kinase by long-chain fatty acid, glucose and insulin in rat primary adipocytes.

Authors:  Abdel Hebbachi; David Saggerson
Journal:  Biosci Rep       Date:  2012-12-13       Impact factor: 3.840

7.  Regulation of insulin resistance and adiponectin signaling in adipose tissue by liver X receptor activation highlights a cross-talk with PPARγ.

Authors:  Fenping Zheng; Saifei Zhang; Weina Lu; Fang Wu; Xueyao Yin; Dan Yu; Qianqian Pan; Hong Li
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.